142 related articles for article (PubMed ID: 14302149)
41. AMMONOACETALS. I. A NEW CLASS OF POTENTIAL ANTINEOPLASTIC COMPOUNDS.
ABBISS TP; SOLOWAY AH; MARK VH
J Med Chem; 1964 Sep; 7():644-5. PubMed ID: 14233178
[No Abstract] [Full Text] [Related]
42. AZETEPA (NSC-64826) IN STAGE IV BREAST CANCER.
FALKSON G; FALKSON HC
Cancer Chemother Rep; 1964 Dec; 43():19-24. PubMed ID: 14250646
[No Abstract] [Full Text] [Related]
43. SYNTHESIS OF N-ALLYLSALICYLAMIDE AND O, (N-ALLYLCARBAMYL)-PHENOXYACETIC ACID.
MUELLER WH; HEYNDRICKX A
J Pharm Belg; 1964; 19():436-41. PubMed ID: 14223997
[No Abstract] [Full Text] [Related]
44. CATECHOL MONOGLYCERYL ETHER CARBAMATES.
SWIDINSKY J; KERVENSKI J; BROWN BB
J Pharm Sci; 1963 Oct; 52():955-8. PubMed ID: 14076503
[No Abstract] [Full Text] [Related]
45. AROMATIC FLUORINE COMPOUNDS. XII. N-(FLUOROPHENYL) CARBAMATES.
FINGER GC; DICKERSON DR; ORLOPP DE; EHRMANTRAUT JW
J Med Chem; 1964 Jul; 7():572-3. PubMed ID: 14221153
[No Abstract] [Full Text] [Related]
46. FURTHER INVESTIGATIONS OF HETEROCYCLIC ALKYLATING AGENTS.
PRESTON RK; PECK RM; BREUNINGER ER; MILLER AJ; CREECH HJ
J Med Chem; 1964 Jul; 7():471-80. PubMed ID: 14221129
[No Abstract] [Full Text] [Related]
47. [On the cytostatic effect of new synthetic carbamoyl esters "in vivo". 1].
Demetrescu C; Gheorghiu P; Görk E; Chirită C; Mavrodin A; Teitel A
Pharmazie; 1965 Oct; 20(10):634-6. PubMed ID: 5880091
[No Abstract] [Full Text] [Related]
48. ENZYME-ALTERABLE ALKYLATING AGENTS. VII. THE DESIGN OF SHORT-LIVED MUSTARDS.
SASS S; WILLIAMSON CE; KRAMER SP; GOODMAN LE; ULFOHN A; SELIGMAN AM; WITTEN B
J Med Chem; 1965 Jan; 8():14-7. PubMed ID: 14287258
[No Abstract] [Full Text] [Related]
49. CARBAMATES DERIVED FROM AMINOPURINES.
DYER E; REITZ JM; FARRIS RE
J Med Chem; 1963 May; 6():289-91. PubMed ID: 14185985
[No Abstract] [Full Text] [Related]
50. Synthesis and testing of quinone-based bis(2,2-dimethyl-1-aziridinyl)phosphinyl carbamates as radiation-potentiating antitumor agents.
Zhang SF; Earle J; MacDiarmid J; Bardos TJ
J Med Chem; 1988 Jun; 31(6):1240-4. PubMed ID: 3373492
[TBL] [Abstract][Full Text] [Related]
51. DICARBAMATES AND THIOLCARBAMATES.
DESTEVENS G; SKLAR M; LUKASZEWSKI H; WITKIN L
J Med Pharm Chem; 1962 Sep; 5():919-24. PubMed ID: 14056435
[No Abstract] [Full Text] [Related]
52. COLORIMETRIC METHOD FOR DETERMINATION OF URACIL MUSTARD AND RELATED ALKYLATING AGENTS.
PETERING HG; VANGIESSEN GJ
J Pharm Sci; 1963 Dec; 52():1159-62. PubMed ID: 14088966
[No Abstract] [Full Text] [Related]
53. PHOSPHORUS-NITROGEN COMPOUNDS. 3. PHENYL ESTERS OF N-TOLYL-AND N-PYRIDYLTHIOCARBAMYLPHOSPHORAMIDIC ACIDS.
CATES LA; FERGUSON NM
J Pharm Sci; 1965 Feb; 54():331-2. PubMed ID: 14293836
[No Abstract] [Full Text] [Related]
54. PHOSPHORYLATED ALKYLATING AGENTS RELATED TO DL-PHENYLALANINE.
MARTINEZ AP; LEE WW; GOODMAN L
J Med Chem; 1964 Mar; 7():224-8. PubMed ID: 14187381
[No Abstract] [Full Text] [Related]
55. Chromatography of alkylating agents. I. Aziridines, nitrogen and sulfur mustards and related derivatives.
Fishbein L; Falk HL
Chromatogr Rev; 1969 Mar; 11(2):101-52. PubMed ID: 4976850
[No Abstract] [Full Text] [Related]
56. PYRIMIDINECARBAMATES AND THIOLCARBAMATES DERIVED FROM AMINO-AND OXOPYRIMIDINES. II.
DYER E; RICHMOND H
J Med Chem; 1965 Mar; 8():195-200. PubMed ID: 14332659
[No Abstract] [Full Text] [Related]
57. 1-(BETA-CHLOROETHYL)-3-CARBAMYLPYRIDINIUM CHLORIDE. PROTOTYPE OF A NEW CLASS OF LATENTLY CYTOTOXIC POTENTIAL ANTITUMOR AGENTS.
FRIEDMAN OM; POLLAK K; KHEDOURI E
J Med Chem; 1963 Jul; 6():462-3. PubMed ID: 14184911
[No Abstract] [Full Text] [Related]
58. COMPARATIVE HYDROLYTIC RATES OF SOME TROPINE ESTERS.
PATEL JM; LEMBERGER AP
J Pharm Sci; 1963 Dec; 52():1129-33. PubMed ID: 14088959
[No Abstract] [Full Text] [Related]
59. POTENTIAL CARCINOLYTIC AGENTS. I. DERIVATIVES OF P,P-BIS(1-AZIRIDINYL)PHOSPHINIC AMIDE.
FRIEDMAN OM; LEVI RS; PAPANASTASSIOU ZB; WHALEY WM
J Med Chem; 1963 Jul; 6():449-50. PubMed ID: 14184905
[No Abstract] [Full Text] [Related]
60. Effects of meturedepa (NSC-51325) in 233 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.
Moore GE; Bross ID; Ausman R; Nadler S; Jones R; Slack N; Rimm AA
Cancer Chemother Rep; 1968 Oct; 52(6):667-73. PubMed ID: 4895430
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
